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Objectives. We evaluated the relationship between alterations
in coronary flow velocity during the acute phase of acute myocar-
dial infarction (AMI) and the recovery of left ventricular wall
motion in patients who underwent successful primary angioplasty.
Background. The status of the coronary microcirculation is the
major determinant of the prognosis of patients who have had
successful reperfusion after AMI. Animal studies have shown that
dynamic changes in regional flow are associated with the extent of
infarction. Evaluation of alterations in coronary flow velocity in
infarcted arteries may provide information about microcircula-
tory damage.
Methods. Flow velocity of the distal anterior descending artery
was continuously monitored with the use of a Doppler guide wire
immediately after recanalization for 18 6 4 h in 19 patients who
underwent successful primary angioplasty after anterior AMI.
Subjects were divided into two groups on the basis of the time
course of alterations in average peak velocity (APV). Group D
consisted of patients who had progressive decreases in APV
through the next day (n 5 9), and Group I comprised patients
with an increase in APV after a transient decline (n 5 10).
Ejection fraction (EF) and regional wall motion (RWM) were
assessed by left ventriculography performed on admission and at
discharge.
Results. The APV at the end of monitoring was greater in group
I than in group D. In group I, EF and RWM were significantly
improved at discharge. The change in EF was greater in group I
than in group D (17 6 9% vs. 4 6 9%, p 5 0.007), as was the
change in RWM (0.96 6 0.23 vs. 0.13 6 0.36 SD/chord, p <
0.0001).
Conclusions. The alteration in flow velocity in recanalized
infarcted arteries is related to left ventricular recovery. A progres-
sive decrease in velocity after angioplasty implies no reflow, which
is associated with a poor recovery of left ventricular function.
Reperfusion injury may account in part for this phenomenon.
(J Am Coll Cardiol 1998;32:338–44)
©1998 by the American College of Cardiology
Reperfusion therapy is an established method of salvaging the
infarcted myocardium of patients who have had an acute
myocardial infarction (AMI) (1,2). However, recent studies
have shown that successful reperfusion of an occluded epicar-
dial coronary artery does not always lead to preservation of left
ventricular function (3). Experiments in animals suggest that
the no reflow phenomenon or reperfusion injury is the major
reason that left ventricular function can not be salvaged, even
after adequate recanalization (4–6). Reflow may be impaired
for several hours after recanalization, a deleterious effect
caused by progressive decreases in regional flow associated
with microvascular occlusion in the myocardium (7,8). Other
animal experiments have shown that microvascular damage
might be reversible after coronary reflow (9–11).
Measurement of coronary vein flow has been used to
evaluate serial changes in perfusion status in patients who have
had AMI (12). No reflow (that is, absence of myocardial
perfusion even after successful recanalization) has been dem-
onstrated using contrast echocardiography (6,11,13). This
method is hampered by procedural complexity and difficulties
in continuous assessment.
The recently developed Doppler guide wire has been used
to evaluate the severity of coronary stenosis or the state of
microvascular perfusion. The instantaneous spectral peak ve-
locity has been validated as an accurate correlate of absolute
flow (14,15). Continuous flow velocity monitoring in the cath-
eterization laboratory has been found to be safe and useful
(16). Thus, we used this method to ascertain whether the
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pattern of alteration in flow velocity indicates myocardial
perfusion status after reflow has been attempted by primary
percutaneous transluminal coronary angioplasty (PTCA).
Methods
Patient population. We continuously monitored flow ve-
locity of an infarcted artery after successful primary angio-
plasty was performed in 47 patients between March 1993 and
February 1997. Six patients with inferior infarctions and two
with posterolateral infarctions were not included in the study.
Patients with previous infarction late recanalization (elapsed
time .12 h), distal culprit lesion and suboptimal PTCA results
were also excluded. The remaining 29 patients with a first
anterior AMI who underwent early recanalization of the left
anterior descending artery within 12 h of onset of chest pain
were enrolled in this study. The diagnosis of AMI was based on
the symptom of severe chest pain lasting more than 20 minutes,
electrocardiographic findings corresponding to ST segment
elevation over the chest leads and an increase of the creatine
kinase level to more than twice the normal value. Moreover, 10
patients were excluded from the present study for the following
reasons: spontaneous guide wire dislocation at the mid-stage of
monitoring (two patients), monitoring duration less than 12
hours (two patients), spontaneously recanalized infarcted ar-
tery (four patients) and no follow-up angiography (two pa-
tients). Therefore, the final study population consisted of 19
patients. The average duration of continuous monitoring was
18 6 4 h (range, 12 to 26 h). Written informed consent was
obtained from each subject. The study protocol was approved
by the committee on Clinical Research of Toho University
Ohashi Hospital.
Direct angioplasty. After intracoronary administration of
2.5 mg of isosorbide dinitrate, multiple orthogonal coronary
projections were obtained. We performed PTCA according to
the clinical protocol used at our institution. Dilation with use
of a conventional balloon was concluded when the residual
stenosis was less than 30% of the diameter by quantitative
analysis. The primary stent implantation was not performed in
this protocol.
Monitoring of continuous flow velocity. The technique of
continuous flow velocity monitoring has been reported in
detail (17). In brief, a Doppler guide wire was placed more
than 4 cm distal to the lesion. The location of the wire tip was
confirmed by fluoroscopic guidance. After PTCA, the balloon
catheter was withdrawn from the guiding catheter, leaving the
guide wire in the coronary artery. The guiding catheter was
dislodged from the left main ostium. The entire system was
sutured and secured to the patient’s leg. Patients were then
moved to the coronary care unit for observation. They re-
mained at rest during monitoring.
The average peak velocity (APV) was automatically calcu-
lated with a fast Fourier transformation and displayed on a
Doppler velocimeter (FloMapr, Cardiometrics, Mountain
View, CA). Studies were recorded onto VHS videotape and
prints were made at various times. The APV value was
determined every 2 to 4 hours, beginning 15 minutes after
PTCA and ending the next day. Systemic blood pressure and
heart rate were also recorded serially. If an intraaortic balloon
pump (IABP) was used, it was turned off for at least 5 minutes
during the velocity measurement. No complications related to
intracoronary guide wire placement occurred in this study.
Classification of APV time course alterations. The time
course pattern was recognized from velocity plots at various
times, determined arbitrarily. The patients were divided into
two groups, on the basis of the pattern of flow velocity
alteration assessed by advent point of minimum APV. Group
D consisted of nine patients who showed progressive decreases
in APV from 4 h after intervention to the end of monitoring.
Therefore, the minimum APV of this group occurred at the
end of continuous monitoring. Group I consisted of 10 patients
who showed gradual increments of APV after a transient
decrease 4 to 8 h after primary PTCA. In this group, the
minimum APV value was found 4 to 8 h after PTCA (4 h in six
patients, 6 h in one and 8 h in three). In 4 of 10 patients, the
maximum APV value was at the end of continuous monitoring.
Angiographic data analysis. The severity of coronary nar-
rowing was determined by angiography using an automated
edge detection algorithm (CCIP-310, Cathex, Tokyo, Japan) in
multiple orthogonal views. The guiding catheter was used as a
reference. The percent diameter stenosis and the minimum
luminal diameter were determined. The development of col-
laterals were graded angiographically according to the Rentrop
classification (18). Well-developed collaterals were defined as
grade 2 or 3. Angiographic slow flow of the left anterior
descending artery after angioplasty was defined as poor con-
trast run-off compared with that of the circumflex coronary
artery, without angiographically apparent dissection or distal
embolization (19–21). Angiograms were visually evaluated by
two independent physicians who had no knowledge of the flow
velocity data.
Medication protocol. All patients received a bolus intrave-
nous injection of 10,000 U of heparin before intervention. The
intravenous infusion of heparin was continued until the next
day (10,000 U for 24 h). Additionally, trans-guiding catheter
administration (100 U/h) of heparin was also continued during
monitoring to prevent thrombus formation in the catheter. As
an antiplatelet agent, aspirin (162 mg/day) was given orally
alone. Angiotensin-converting enzyme inhibitors (2.5 to 5 mg
of enalapril or 7.5 to 15 mg of delapril) were administered
shortly after intervention and continued throughout the hos-
pital stay. Calcium channel blocking agents or nitrates were
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
APV 5 average peak velocity
EF 5 ejection fraction
IABP 5 intraaortic balloon pump
PTCA 5 percutaneous transluminal coronary angioplasty
RWM 5 regional wall motion
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administered to some patients who had a hypertensive ten-
dency during the acute stage of infarction. None of the subjects
received beta blockers, catecholamines, other inotropic agents
or drugs that exerted a cardioprotective action (such as vera-
pamil, papaverine, or adenosine) (22–24).
Evaluation of left ventricular function. Left ventriculo-
grams were obtained at a 30° right anterior oblique projection
with contrast medium. The protocol called for a 9-in. image
intensifier and a filming rate of 30 frames per second. The
global left ventricular ejection fraction (EF) was evaluated by
the area-length method and regional wall motion (RWM) by
the center-line method.
Left ventriculography was performed on admission (before
angioplasty) and at discharge (16 6 6 days later). Both EF and
RWM were compared between the groups. All measurements
were performed by a physician who had no knowledge of the
Doppler flow velocity data.
Statistics. Statistical analysis was performed using Stat-
View 4.02 on a Macintosh Centris 650 computer. Continuously
distributed variables were expressed as mean 6 standard
deviation. The unpaired t test was used to compare clinical
determinants and velocity values; an F test was applied. Other
variables were compared using the Mann-Whitney U test. The
paired t test was used to evaluate serial changes in hemody-
namics and angiographic variables. The pattern of the APV
time course alteration in groups D and I was defined by
two-way repeated analysis of variance. Categoric variables
were compared by Fisher’s exact test. A level of p , 0.05 was
considered statistically significant.
Results
Clinical characteristics. The study population consisted of
15 men and 4 women, with a mean age of 64 6 9 years (range
50 to 79 years). The average elapsed time from AMI onset to
recanalization was 4.5 6 2.5 h. Antecedent angina, defined as
some chest symptoms within the 24 h before the onset of
infarction, was present in 11 patients.
Baseline clinical characteristics of the two groups are listed
in Table 1. There were no differences between groups D and I
in age, gender, history of antecedent angina, elapsed time from
onset to recanalization or peak creatine kinase value. In group
D, four patients belonged to Killip class 1 and five patients to
Killip class 2; in group I, 9 of 10 patients belonged to Killip class
1. The frequency of IABP use was similar in both groups. The
reason for IABP use was maintenance of patency after angio-
plasty. The counter pulsation assist was stopped within 24
hours after angioplasty on the day after angioplasty in all
patients.
Angiographic characteristics in both groups are given in
Table 2. There were no differences in baseline antegrade flow,
the frequency of well-developed collaterals and the lesion
location.
Time course of alterations in flow velocity. Data from APV
monitoring in each patient are shown in Figure 1. The data
showed a unique time course of alteration in velocity through-
out monitoring. In all patients, the difference between maxi-
mum and minimum APV was more than 30%. Group D
showed an average 56 6 11% decrease in APV (range 39% to
67%) from maximum value (Fig. 1A), and lowest APV oc-
curred at the end of monitoring. In group I, the APV was
lowest within 4 to 8 h after PTCA (average 47 6 10% decrease
from baseline, range 30% to 57%) and then showed an average
95 6 43% increase from its lowest point (range 41% to 193%)
(Fig. 1B).
The APV values 15 minutes after PTCA and 4 h later were
similar in both groups. However, group I had a higher APV at
the end of monitoring than group D (21 6 9 cm/sec vs. 9 6 4
cm/sec, p 5 0.002). The time course of alteration in APV
values at these three points was markedly different in the two
groups (p , 0.0001). (Fig. 2). Cyclical flow variation, as noted
by Anderson et al. and Kern et al. (16,25), was not observed in
any patients.
Comparison of angiographic findings. The lesion in each
patient was in the proximal left anterior descending artery.
Angiographic slow flow on the final angiogram was found in 6
(67%) patients in group D. In contrast, no slow flow was found
in group I (Table 2). In all patients, good patency of the
infarcted artery endured at discharge. In group D, the percent
diameter stenosis of the culprit lesion before angioplasty,
immediately after angioplasty and before discharge was 90.9 6
10.9%, 22.1 6 6.2% and 20.4 6 5.1%, respectively. In group I,
these values were 90.5 6 10.3%, 23.7 6 7.2% and 26.6 6 5.1%,
respectively. There were no differences between the groups.
Hemodynamics. Mean arterial pressure measurements 15
minutes after primary PTCA, 4 h later and at the end of
monitoring were similar in both groups. No significant time
course variances in hemodynamics were observed throughout
the study between the groups. Similarly, the heart rate was not
different between the groups. There was no difference in left
ventricular end-diastolic pressure measured before the reper-
fusion procedure (Table 3).
Recovery of left ventricular function. The EF on admission
was 48 6 12% in group D and 46 6 9% in group I (p 5 0.67).
The EF at discharge was 52 6 14% in group D and 62 6 8%
Table 1. Clinical Characteristics of 19 Patients
Characteristic
Group D
(n 5 9)
Group I
(n 5 10)
p
Value
Age (yr) 63 6 10 65 6 8 0.66
Male (%) 89 70 0.58
Antecedent angina (%) 56 60 .0.99
Functional class
Killip class 1 (%) 44 90 0.057
Forrester subset 1 (%) 78 100 0.21
Elapsed time (h) 5.1 6 3.0 4.0 6 2.0 0.35
Peak creatine kinase (U/l) 5,867 6 3,846 3,752 6 1,319 0.12
Duration of monitoring (h) 19 6 5 17 6 4 0.49
Follow-up angiography (d) 17 6 4 16 6 2 0.37
IABP use (%) 33 20 0.62
Elapsed time 5 time from last severe chest symptom to angioplasty; IABP 5
intraaortic balloon pump.
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in group I (p 5 0.071). The change in EF was significantly
greater in group I than in group D (17 6 9% vs. 4 6 9%, p 5
0.007) (Fig. 3A).
The RWM on admission was 23.00 6 0.31 SD/chord in
group D and 22.95 6 0.23 SD/chord in group I (p 5 0.75). The
RWM at discharge was 22.87 6 0.46 SD/chord in group D and
21.99 6 0.42 SD/chord in group I (p 5 0.0004). The change in
RWM was significantly greater in group I than in group D
(0.96 6 0.23 vs. 0.13 6 0.36, p , 0.0001) (Fig. 3B). In three
patients in group D, RWM was worse at discharge than on
admission.
Discussion
Animal studies have demonstrated that microvascular oc-
clusion can develop in the area at risk after reperfusion,
resulting in a progressive decrease in regional flow (3,7,8,26).
No reflow has been shown to develop and progress for several
hours after recanalization (7,8,27). Thus, the evaluation of flow
changes after restoration of an occluded infarcted artery could
provide useful information about the effects of the reperfusion
procedure on myocardial salvage in the clinical setting. We
found that the pattern of alterations in flow velocity in the
successfully recanalized artery was related to recovery of left
ventricular function.
Left ventricular function in patients with AMI is deter-
mined by several factors, including the area at risk supplied by
the infarcted artery, development of collateral flow (28,29),
elapsed time after PTCA and the presence of antecedent
angina (12,30,31). The number of electrocardiographic leads
with ST segment elevation did not differ between groups.
Additionally, the lesion location was similar in both groups.
Thus, the extent of myocardium at risk appeared to be similar
in both groups. Other clinical characteristics, including collat-
eral grading and elapsed time, were not different in the two
groups. It seems reasonable that the recovery of the infarct-
related region of the left ventricle depends on the pattern of
alteration in flow velocity after reperfusion in patients who
have undergone successful primary PTCA.
Proposed mechanism of flow velocity alteration. Several
factors could determine the blood flow in the region of
infarction, including collateral circulation, severity of stenosis,
Figure 2. Difference in time course of APV alterations between group
D (lines with solid circles) and group I (lines with open squares) was
significant (p , 0.0001) by two-way repeated analysis of variance. The
APV at 15 minutes after PTCA and 4 h later in group D were 19.4 6
5.4 and 15.0 6 7.3 cm/sec, respectively, whereas those in group I were
20.7 6 6.6 and 13.4 6 7.5 cm/sec, respectively. Group I showed a larger
APV at the end of monitoring than group D (21.2 6 9.1 vs. 9.0 6
3.5 cm/sec).
Table 2. Angiographic Characteristics
Characteristic Group D Group I
p
Value
Baseline TIMI flow
TIMI 0 6 6 .0.99
TIMI 1 1 2 3 4
Collateral grade
Poorly developed 6 6 .0.99
Well developed 3 4
Lesion location proximal of major
septal branch (%)
56 50 .0.99
Angiographic slow flow after
angioplasty (%)
67 0 0.003
TIMI 5 Thrombolysis in myocardial infarction.
Figure 1. A, Time course of alterations in APV in nine
patients (group D) who showed progressive decrease in
velocity throughout monitoring. The average percent de-
crease in velocity from the maximum to the minimum value
was 56%. B, Time course of alterations in APV in 10
patients (group I) who showed a gradual increase in velocity
after a transient decrease 4 to 8 h after PTCA. The average
percent increase in velocity from the minimum to the
maximum value was 95%.
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blood viscosity, flow reserve capacity (32), preload and after-
load and the extent of the reperfusion injury (33,34). There-
fore, it is difficult to evaluate the microvascular flow to the
infarcted myocardium from the APV of the restored infarcted
artery alone. Heart rate and blood pressure were not signifi-
cantly different between groups. We cannot exclude the possi-
bility that vasomotion alteration at the target lesion occurred
during monitoring. However, our preliminary study of patients
who had serial coronary angiography immediately after angio-
plasty, at the end of monitoring, and before discharge showed
no deterioration in the residual stenosis. Residual stenosis
appeared to remain constant. Moreover, flow velocity accu-
rately correlates with absolute flow (14,15). Thus, we conclude
that the dynamic alterations in flow velocity observed in this
study accounted for the changes in blood supply to the
infarcted myocardium. Previous animal studies have shown
that no reflow associated with microvascular occlusion may
progress for several hours after reperfusion (7) and that the
extent of perfusion 4 h later after reflow correlated well with
left ventricular prognosis (8).
In other studies (12,35), progressive decreases in cardiac
vein flow suggestive of the no reflow phenomenon were
observed in patients with AMI who underwent successful
recanalization. In group D the extent of APV reduction during
monitoring was 56 6 11% (range 39% to 67%). This finding is
consistent with results of a previous study in which no reflow
was related to a .30% decrease from baseline cardiac vein
flow during 24 h of monitoring (12). Progressive decreases in
APV might indicate severe deterioration in perfusion, most
likely attributable to progression of the no reflow phenomenon
that is based on development of reperfusion injury. Con-
versely, a gradual increase in flow velocity might be explained
by amelioration of tissue perfusion status. Temporary and
reversible causes of poor perfusion include microvascular
occlusion by blood cell stasis (36), vessel compression with
myocardial tissue swelling (37), hyperreactivity of vascular
tonus (38) and prolonged spasms (22). Resolution of pro-
longed reactive hyperemia followed by restoration of occluded
infarcted arteries might also contribute to the mechanisms of
initial reduction of flow velocity, but this conclusion remains
speculative.
Although coronary flow reserve measurement was not
performed in the present study, it might be useful for detecting
nonuniform distribution of myocardial infarction. Serial coro-
nary flow reserve measurements might lead to better under-
standing of the alterations in flow velocity observed in this
study.
Study limitations. Flow velocity is parallel to absolute
volumetric flow only when the cross-sectional area in examined
vessels remains constant. None of our subjects showed signif-
icant lesion renarrowing at discharge. However, we did not
confirm the lumen area by intravascular ultrasound. Further-
more, we cannot exclude the possibility that vasomotion after
angioplasty is related to flow alteration. Continuous intrave-
nous infusion of nitrate and stent implantation could help to
eliminate and minimize the alteration of vasomotion and help
maintain vessel dilation.
Absolute coronary flow is also dependent on heart rate,
afterload and contractility. Although those factors were con-
stant in both groups, we could not monitor the left ventricular
end-diastolic pressure serially, which would have altered flow
in the area at risk.
From a technical point of view, cardiac vein flow measure-
ments are limited by difficulty in stabilizing catheter position
and by lack of specificity for detecting changes in coronary
artery flow (39,40). It is difficult to monitor flow status contin-
uously by myocardial contrast echocardiography to detect the
no reflow phenomenon after reperfusion therapy. Continuous
coronary flow velocity monitoring has major advantages in
real-time evaluation of reflow status. No special equipment
and skills are needed in emergency situations. The perfor-
mance issue regarding monitoring is positioning the guide wire
tip and guide catheter. These were important technical prob-
lems (41). The true damage in the infarcted myocardium might
Figure 3. A, No difference in global EF was observed between group
D (solid bars) and group I (open bars) at discharge (left). The change
() in EF was significantly smaller in group D (*p 5 0.007) (right). B,
RWM at discharge improved significantly in group I (22.87 6
0.46 SD/chord in group D vs. 21.99 6 0.42 SD/chord in group I, *p 5
0.0004) (left). The change () in RWM was markedly greater in group
I (**p , 0.0001) (right).
Table 3. Hemodynamic Variables
Variable Group D Group I p Value
Mean blood pressure (mm Hg)
15 min 100 6 6 98 6 9 0.71
4 h 97 6 7 96 6 8 0.92
Next day 99 6 9 97 6 5 0.60
Heart rate (bpm)
15 min 81 6 11 79 6 13 0.80
4 h 80 6 11 77 6 10 0.44
Next day 84 6 13 74 6 10 0.07
LVEDP (mm Hg)
Before angioplasty 23 6 6 21 6 4 0.55
LVEDP 5 left ventricular end-diastolic pressure; Next day 5 at the end of
monitoring.
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not have been examined completely because a stunned myo-
cardium might not have been restored at discharge (42).
Clinical implications. Data obtained by monitoring flow
velocity could be important for risk stratification of patients
with AMI who have undergone primary PTCA. Deterioration
in flow velocity during monitoring may be related to infarct
expansion and left ventricular remodeling. Moreover, this
study shows that evaluation of alterations in flow velocity after
primary PTCA might provide insight into dynamic changes of
reperfusion status.
Intraaortic balloon pumping could augment myocardial
perfusion and result in myocardial salvage (43,44). Drugs such
as verapamil (20,22) and adenosine (24,45) might modulate
reperfusion injury. Flow velocity monitoring might make it
possible to study the pharmacologic responsiveness of the
resistance vessels of infarcted regions.
Prolonged velocity monitoring after successful primary an-
gioplasty demonstrated two different time patterns of change
in flow velocity. Progressive decrease of average velocity in the
late stage is associated with poor recovery of left ventricular
function, which is hypothesized to be related to regional
impaired perfusion. The method described here could become
a useful predictor of reflow status in patients with AMI.
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